Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Quizzes

Quiz
Identifying Preferred H2 Blocker for Treating GERD in Breastfeeding Patients
09/26/2022
Which histamine H2-receptor antagonist is considered the preferred option for managing heartburn in patients who are lactating?
Which histamine H2-receptor antagonist is considered the preferred option for managing heartburn in patients who are lactating?
Which histamine H2-receptor...
09/26/2022
Pharmacy Learning Network
Quiz
Reviewing Response Rates for Chemoablative UTUC Therapy Option
09/15/2022
Among patients with low-grade upper tract urothelial carcinoma enrolled in an open-label, single-arm, phase 3 trial, delivering chemoablative therapy to the upper tract via a reverse-thermal hydrogel led to a complete response rate of which...
Among patients with low-grade upper tract urothelial carcinoma enrolled in an open-label, single-arm, phase 3 trial, delivering chemoablative therapy to the upper tract via a reverse-thermal hydrogel led to a complete response rate of which...
Among patients with low-grade...
09/15/2022
Pharmacy Learning Network
Quiz
Weighing Options for Patients With Upper Tract Urothelial Carcinoma
08/17/2022
Patients with low-grade upper tract urothelial carcinoma always undergo radical nephroureterectomy to avoid further complications.
Patients with low-grade upper tract urothelial carcinoma always undergo radical nephroureterectomy to avoid further complications.
Patients with low-grade upper...
08/17/2022
Pharmacy Learning Network

Advertisement

A vaccine
Quiz
Predictors of Influenza Vaccine Hesitancy
03/31/2022
Researchers recently investigated influenza vaccine hesitancy among rheumatology patients. Do you know which issues were the biggest contributors?
Researchers recently investigated influenza vaccine hesitancy among rheumatology patients. Do you know which issues were the biggest contributors?
Researchers recently...
03/31/2022
Rheumatology & Arthritis
SPONSORED QUIZ BY SANOFI
Treatments in Multiple Myeloma
02/01/2022
  INDICATION SARCLISA (isatuximab-irfc) is indicated: In combination with carfilzomib and dexamethasone, for the treatment of adult patients with relapsed or refractory multiple myeloma who have received 1 to 3 prior lines of...
  INDICATION SARCLISA (isatuximab-irfc) is indicated: In combination with carfilzomib and dexamethasone, for the treatment of adult patients with relapsed or refractory multiple myeloma who have received 1 to 3 prior lines of...
  INDICATION SARCLISA...
02/01/2022
Pharmacy Learning Network
Quiz
Understanding Overnight Symptoms of Heartburn
12/22/2021
How many US adults who have heartburn at least once a week report experiencing symptoms overnight?
How many US adults who have heartburn at least once a week report experiencing symptoms overnight?
How many US adults who have...
12/22/2021
Pharmacy Learning Network

Advertisement

Quiz
Preventing Symptoms of Heartburn
12/22/2021
True or False: Eating more food can help reduce heartburn symptoms.
True or False: Eating more food can help reduce heartburn symptoms.
True or False: Eating more food...
12/22/2021
Pharmacy Learning Network
Quiz
Identifying Active Ingredients for Treating Heartburn
10/16/2021
What kind of active ingredient is famotidine?
What kind of active ingredient is famotidine?
What kind of active ingredient...
10/16/2021
Pharmacy Learning Network
Quiz
Overnight Remedies for Heartburn
10/16/2021
True or False: Antacids and H2 blockers both provide stomach acid control through the night.
True or False: Antacids and H2 blockers both provide stomach acid control through the night.
True or False: Antacids and H2...
10/16/2021
Pharmacy Learning Network

Advertisement

Quiz
How to Relieve Heartburn
10/07/2021
Can you identify remedies for heartburn from the following list?
Can you identify remedies for heartburn from the following list?
Can you identify remedies for...
10/07/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use